Cosmo Bio Antibodies for Plant Cells
29 June, 2012Cosmo Bio has released antibodies for plant cells which can detect transporters localised in cell membranes and enzymes.
Lunginnov tools to study endothelial dysfunction
23 May, 2012Lunginnov has developed a range of products for the detection of Endocan/ESM-1 (endothelial cell-specific molecule 1). Endocan has been shown to be an effective biomarker of endothelial activation and dysfunction in a number of disease states including human lung, liver, brain and kidney cancers and in severe sepsis.
Cosmo Bio appoints Australian distributor
31 January, 2012Cosmo Bio has appointed United Bioresearch as its Australian distributor.
Innova Biosciences AbSelect Antibody Purification System
15 August, 2011 byThe Innova Biosciences AbSelect Antibody Purification System readily removes unwanted substances such as proteins, preservatives and amino acids that can interfere with labelling reactions. It can either be used to purify antibodies from crude samples such as ascites fluid or serum, or from poor buffer formulations which may contain high concentrations of BSA, azide or Tris.
ProSpec-Tany Technogene’s bacteria derived recombinant proteins
07 October, 2010 byProSpec-Tany Technogene’s bacteria derived recombinant proteins feature high purity and biological activity. ProSpec also offers in-house custom production services of recombinant proteins.
Single Chain Fv Fragments
07 October, 2010 bySingle Chain Fv Fragments (scFvs) are recombinant antibody fragments consisting of a full variable (epitope-binding) region of an immunoglobulin heavy chain covalently linked to the variable region of an immunoglobulin light chain.
Innova Biosciences Lightning Link antibody labelling kits
03 September, 2010The Innova Biosciences Lightning Link antibody labelling kits are easy to use and require only 30 s hands-on time. The kits require no separation steps, which allows for 100% antibody recovery, and come in over 40 labels including the FluoProbes range.
Innova Biosciences Lightning-Link antibody labelling kits
09 August, 2010Innova Biosciences Lightning-Link kits are a one-step conjugation method, which simplifies the production of labelled antibodies. It is claimed that only 30 s hands-on time is required. The antibody is simply added to the Lightning-Link reaction mix and the label is covalently bound to the antibody in a gentle, controlled process. Furthermore, as there are no columns or other separation steps, antibody recovery is close to 100%.
ALBAcheck-BGS Sensitivity Controls
30 November, 2009 byAlba Bioscience has added Anti-S (weak) to its range of control reagents namely, Anti-c (weak), Anti-Fya (weak), Anti-K (weak) and Anti-E (weak).
Lonza Potelligent CHOK1SV host cell line
20 November, 2009 byPotelligent CHOK1SV, a host cell line for manufacturing recombinant antibodies, combines BioWa’s glycosylation Potelligent technology with Lonza’s GS Gene Expression System and CHOK1SV.
Simplifying antibody conjugation processes
10 September, 2009Innova Biosciences has developed a conjugation technology called Lightning-Link that eliminates almost all of the steps employed in a traditional conjugation process.
Method to stabilise antibodies
07 September, 2009A technique for stabilising enzymes could lead to better biosensors, disease therapeutics and diagnostic reagents and non-laboratory applications, including environmental remediation.
High specificity clonal antibodies
08 July, 2009DB Biotech has introduced a new technology for the production of highly specific RABBIT CLONAL antibodies. In vitro cloning technology developed by the company enables the preparation of a pure immunoglobulin fraction corresponding to a single clone of B lymphocytes.
Range of antibodies
10 June, 2009Now available for the first time in Australia, the complete range of antibodies from Proteintech Group, Inc (PTG).
USP-NF compliant recombinant human albumins
09 June, 2009 byNovozymes Biopharma has announced that its Recombumin and albucult products comply with the new excipient monograph standard for recombinant human albumin, published in the United States Pharmacopoeia — National Formulary (USP-NF). The monograph was first published in November 2008 and became official on 1 May 2009. As these products comply with the monograph, their use eases the regulatory process for users and sets the industry benchmark for recombinant human albumin.
